biotech · WHIM Syndrome · Neutropenias · XFOR
X4 Pharmaceuticals
X4 Pharmaceuticals, Inc
X4 Pharmaceuticals trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 61 N Beacon St, Boston, Massachusetts 02134, US
- Founded
- 2014
- Employees
- 81
- Programs
- 11
- Drugs
- 6
- Patents
- 16
X4 Pharmaceuticals clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to X4 Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
X4 Pharmaceuticals trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for X4 Pharmaceuticals.
-
Mavorixafor, Mavorixafor Placebo Capsules — Phase 3
Clinical update -
Mavorixafor, Placebo to Test IMP — Phase 3
Clinical update -
Mavorixafor — Phase 1
Clinical update -
X4P-001 — Phase 1
Clinical update -
Mavorixafor — Phase 3
Clinical update -
Mavorixafor — Phase 3
Clinical update -
X4P-001 — Phase 2
Clinical update -
X4P-001 — Phase 2
Clinical update